Edwards v. Basel Pharmaceutical

United States Court of Appeals for the Tenth Circuit · 1997 · Torts

Tortsproducts liabilityfailure to warnprescription drugswrongful deathnicotine patchpatient warningphysician warning

Facts

Plaintiff's husband died of a heart attack while smoking cigarettes and wearing two of Basel's Habitrol nicotine patches. Basel provided prescribing physicians with a relatively thorough warning that specifically noted the fatal risk of nicotine overdose from smoking and overuse of the patch, but the patient package insert stated only that an overdose might cause the user to faint. Basel represented that both the patient insert and the physician information were mandated and approved by the FDA. Basel argued that because it had warned the physician and complied with the FDA-mandated patient insert, it could not be liable for inadequate consumer warnings.

Issue

After an FDA mandate requires direct patient warnings for a prescription drug, does Oklahoma law permit a consumer-warning claim even when the manufacturer complied with the FDA requirement? In this rehearing posture, the court also considered whether its earlier certified question and implementation of the Oklahoma Supreme Court's answer were improper because the record did not specify the exact source or details of the FDA mandate.

Rule

When the FDA requires that warnings be given directly to the patient with a prescribed drug, the learned intermediary doctrine does not automatically shield the manufacturer from liability merely because it adequately warned the prescribing physician. Under Oklahoma law, compliance with the FDA's minimum warning requirements does not necessarily satisfy the manufacturer's duty to warn the consumer; the warnings must be nonmisleading and adequate under state common law.

🔒

See the holding & full analysis

Create a free KwikCourt account to unlock the rest of this brief — and practice the case.

The court's holding and reasoning
Doctrine tests, pitfalls & exam hypotheticals
10 practice questions + 4 AI-graded essays on this case

Free sample · practice this case

Test yourself

One of 10 multiple-choice questions for this case. Pick an answer to see why.

In Tulsa, NovaCrest Therapeutics sells a prescription migraine injection. Its materials to physicians prominently warn that combining the drug with a common decongestant can cause a stroke, but the FDA-required patient handout says only that the combination may cause dizziness. After suffering a stroke, Lena Morris sues under Oklahoma law for inadequate consumer warnings.

What is NovaCrest's strongest defense, and how should the court likely rule?

Explanation. Under the majority opinion applying Oklahoma law, when the FDA requires warnings to be given directly to the patient with a prescription drug, the learned intermediary doctrine does not automatically shield the manufacturer merely because the physician was adequately warned. Compliance with the FDA's minimum warning requirement does not necessarily satisfy the manufacturer's common-law duty to warn the consumer; the warning must also be nonmisleading and adequate under state law.